$OSCR revenue growth is still the main reason this company is so interesting to me. The stock can be volatile, and healthcare is never a simple industry, but the top-line growth is hard to ignore. Now the real question is execution. Can Oscar keep growing revenue while improving margins, controlling medical costs, and proving this can become a much more profitable business over time? That is what matters most from here. $OSCR is still one of the more interesting healthcare growth stories in the market.
952 views
0 Comments
Join the conversation with 500,000+ other investors 💸
Create an account to get access to everything Blossom has to offer!
📊 Personalized algorithm based on your investing style, experience level and interests
📈 Powerful portfolio and dividend tracking tools
👀 See what top creators and others in the community are investing in
